Esmolol Mechanism of Action and Clinical Implications

Primary Mechanism and Cardiovascular Effects

• The American College of Cardiology notes that esmolol's competitive blockade prevents norepinephrine and epinephrine from binding to beta-1 receptors, thereby blunting the cardiovascular response to sympathetic stimulation 2
• Slowing heart rate increases diastolic filling time, which can improve coronary perfusion since coronary blood flow occurs primarily during diastole, as reported by the American College of Cardiology and Praxis Medical Insights 2, 1
• Beta-1 receptor blockade impairs the heart's compensatory mechanisms to increase contractility and heart rate under stress, according to the American Society of Anesthesiologists 4, 5

Clinical Implications and Contraindications

• The American Society of Anesthesiologists warns that beta-1 receptor blockade can precipitate heart failure or pulmonary edema by preventing compensatory increases in cardiac output in situations of increased afterload 4, 5
• Praxis Medical Insights recommends that esmolol should not be used in patients with decompensated heart failure, cardiogenic shock, or severe bradycardia, as beta-1 blockade will worsen these conditions 1
• The Intensive Care Medicine journal notes that landiolol is approximately eight times more beta-1 selective than esmolol, though both are ultra-short acting 6